generated by the usage of antimicrobial drugs is absent. She is the author of 14 publications in international journals.

Transcription

1 Fernando Baquero Doctor in Medicine, Ramón y Cajal Research Professor in Bacterial Evolution at the Biomedical Research Foundation and Department of Microbiology of the Ramón y Cajal Universty Hospital. Member of CIBERESP and Associated Scientist at the Astrobiology Center (CSIC) in Madrid. His interests are focused mostly on the biochemistry, genetics, population biology, ecology, and evolution of antimicrobial resistance and virulence in bacterial organisms. He is author of more than 360 papers quoted in PubMed, and listed among ISI-highly cited scientists in Microbiology. Jesús Rodríguez-Baño, MD, PhD Jesús Rodríguez-Baño is head of the Infectious Diseases Unit and associate professor at Hospital Universitario Virgen Macarena in Seville, Spain, where he coordinates the infection control and antimicrobial use program. He is specialist in Internal Medicine and Master in Epidemiology and Clinical Research. His clinical and research activities are mainly focused on antimicrobial use, multi-drug resistant pathogens and nosocomial infections. He is author of more than 80 peerreviewed publications. Richard Bonnet, PhD Richard Bonnet is the Head of the Department of Bacteriology, Mycology and Parasitology at the University Hospital Gabriel Monpied (Clermont-Ferrand, France). He is also Professor of medical bacteriology at Auvergne University in Clermont-Ferrand. His research work is focused on the investigation of structurefunction relationships, which explained the activity and the evolution of betalactamases. He is also member of the editorial board of the Journal Antimicrobial Agents and Chemotherapy.

2 Rafael Cantón, PhD Rafael Cantón is the Head of the Clinical Microbiology Department at the University Hospital Ramón y Cajal (Madrid, Spain) and is associated Professor of Clinical Microbiology at Complutense University in Madrid. His clinical and research work is focussed on antimicrobial resistance mechanisms, particularly on beta-lactamases, cystic fibrosis pulmonary infections, and interplay of clonal epidemiology and resistance. He has published more than 180 articles in medical journals, 40 chapters in teaching books and has participated in numerous congresses. He is also an active member of the European Society for Clinical Microbiology and Infectious Disease, member of the steering committee of EUCAST and associated editor of Clinical Microbiology and Infection journal and member of the editorial board of the Journal of Clinical Microbiology. Teresa M. Coque Dr. Teresa M. Coque, Senior scientist at FIBioHRYC, Ph.D in Molecular Epidemiology and Antibiotic Resistance. Her special interests and expertise include molecular epidemiology, population biology and characterization of integrons, transposon and plasmids of commensal and pathogenic Gram-negative and Gram positive bacteria. TMC has published more than 75 articles in refereed journals, 10 book chapters and more than 150 communications to national and international congresses. She has participated in several EU projects dealing with the characterization of elements involved in bacterial horizontal gene transfer and has been main investigator of different grants. TMC has directed seven doctoral thesis and coordinates research projects of students associated with the programs Leonardo da Vinci ( ) and Erasmus (2007-) (Fondo Social Europeo- Ministerio de Ciencia y Tecnología de Portugal and Hospital Ramón y Cajal).She is member of different scientific committees and associations and she regularly serves as referee of different journals in the microbiology field.

3 Luis Martinez-Martinez, MD, PhD Luis Martinez-Martínez is Specialist in Microbiology and Parasitology. His current position is as Chief of the Service of Microbiology at University Hospital Marqués de Valdecilla in Santander (Spain) and is Associate Professor at the Department of Molecular Biology at University of Cantabria in Santander. His clinical and research work is focussed on antimicrobial resistance (betalactamases, decreased permeability, active efflux; mobile elements, quinolones resistance mechanisms; multiresistant pathogens, nosocomial infections), antimicrobial susceptibility testing (reference and automated systems), in vitro activity of new antimicrobial agents and coryneform bacteria. He has published more than 150 articles in peer-review journals, presented more than 250 abstracts in national and international Congresses and has actively participated in scientific meetings with more than 50 lecturers and conferences. Ferran Navarro, PhD BSc in Biology (1990), MSc in Clinical Microbiology (1992) and PhD in Science (1995) from the Universitat Autònoma of Barcelona. Coordinator of the research area of the Clinical Microbiology Department and Associate Professor of Clinical Microbiology at the Universitat Autònoma of Barcelona. He did part of his training at the Unitée des Agents Antibactériens at the Pasteur Institute, Paris (France) and at Cold Spring Harbor (USA). His clinical and research work is mainly focused on the mechanisms of resistance to antimicrobial agents and rapid diagnosis: mechanisms of resistance to glycopeptides in Enterococcus; resistance to betalactams and aminoglycosides in Enterobacteriaceae and other gram-negative bacilli; and genetic elements able to spread the genes responsible for this resistance. He has over 80 refereed publications in medical journals and has presented his research findings at many national and international congresses, meetings and courses.

4 Patrice Nordmann, MD, PhD Patrice Nordmann is the head of the Clinical Microbiology Department at the University hospital at the University hospital Bicêtre (K. Bicêtre, France) and Professor of Clinical Microbiology at the South Paris Medical School. He is director of the research unit U914 «Emerging resistance to antibiotics» of the INSERM, France. His recent interest has focused on the molecular mechanisms, the biochemistry and epidemiology of emerging resistance determinants in Gram negatives of clinical interest (Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter baumannii). He is co-author of more than 320 peer-reviewed publications. He is member of the editorial board of Antimicrobial Agents and Chemotheray and Associated Editor of Emerging Infectious Diseases. Angela Novais, PhD Ângela Novais is a post-doctoral scientific researcher at the Microbiology Department of the Ramón y Cajal University Hospital (Madrid, Spain). Her research interests focus on population structure analysis and molecular epidemiology of ESBL-producing Enterobacteriaceae, and ecology and evolution of Escherichia coli antibiotic resistant plasmids. She has participated in different national and European scientific projects and networks. She is author of 9 original manuscripts and reviews in international peer-review journals in the microbiology field, and has 25 communications to national and international congresses. Lucia Pallecchi, MD Lucia Pallecchi is Assistant Professor at the Department of Molecular Biology, Microbiology Section of the University of Siena (Siena, Italy). Her research mainly focuses on molecular epidemiology of resistance in clinical and commensal bacteria, study of the mobile genetic elements involved in intra- and inter species dissemination of resistance determinants, and study of the genetic basis of acquired resistance in bacteria from remote areas where the selective pressure

5 generated by the usage of antimicrobial drugs is absent. She is the author of 14 publications in international journals. Laurent Poirel, PhD Laurent Poirel is Associate Researcher of the INSERM (French National Institute of Health and Medical Research) in the Department of Microbiology at Bicêtre hospital, South-Paris Medical School. His research mainly focuses on emerging mechanisms of resistance to ß-lactams and quinolones in Gram-negative rods. He is specialized on the genetics of acquisition of expanded-spectrum ß-lactamases in Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter baumannii, and plasmid-mediated quinolone resistance determinants in Enterobacteriaceae. He is the author of more than 180 publications in international journals. He is member of the Editorial board of the Antimicrobial Agents and Chemotherapy and Clinical Microbiology and Infection journals. Carmen Torres, PhD Carmen Torres is Professor of Biochemistry and Molecular Biology in the University of La Rioja (Logroño, Spain) and Coordinator of Molecular Microbiology Unit at the Center for Biomedical Research of La Rioja (Spain). Her main research work has been focussed on antimicrobial resistance mechanisms in bacteria of different groups (Enterococcus, Enterobacteriaceae, Staphylococcus, among others), of different origins (humans, animals, food and the environment), and of different geographical areas in order to analyse the flow of resistant bacteria and genes in different environments. She has published more than 130 articles in medical journals, and have more than 270 communications on national and international congresses. She has been main researcher of national and international projects, has participated as an expert of the European Food Safety Agency and has been member of the organizing committee of different national and international scientific events.

6 Timothy R. Walsh Professor of Medical Microbiology and Antimicrobial Resistance at Cardiff University, Heath Park Hospital, Cardiff, Wales. His interests are on how bacteria acquire and express resistance genes and molecular surveillance of resistance genes and mobile genetic elements at a global level. Whilst some of his research includes Staphylococcus aureus, most of his research is directed at Gram-negative bacteria, particularly Enterobacteriaceae and Pseudomonas aeruginosa. He also has a research program on antimicrobial peptides. He is a member of many international societies and has presented and published over 320 scientific presentations/papers.